Literature DB >> 11313368

Cutting edge: distinct motifs within CD28 regulate T cell proliferation and induction of Bcl-XL.

J S Burr1, N D Savage, G E Messah, S L Kimzey, A S Shaw, R H Arch, J M Green.   

Abstract

CD28 provides an important costimulatory signal in T cell activation that regulates multiple cellular processes including proliferation and survival. Several signal transduction pathways are activated by CD28; however, the precise biochemical mechanism by which CD28 regulates T cell function remains controversial. Retroviral gene transfer into primary T cells from TCR-transgenic, CD28-deficient mice was used to determine the specific sequences within CD28 that determine function. Discrete regions of the cytoplasmic domain of CD28 were identified that differentially regulate T cell proliferation and induction of the anti-apoptotic protein Bcl-X(L). Mutation of C-terminal proline residues abrogated the proliferative and cytokine regulatory features of CD28 costimulation while preserving Bcl-X(L) induction. Conversely, mutation of residues important in phosphatidylinositol 3-kinase activation partially inhibited proliferation but prevented induction of Bcl-X(L.) Thus the ability of CD28 to regulate proliferation and induction of Bcl-X(L) map to distinct motifs, suggesting independent signaling cascades modulate these biologic effects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313368     DOI: 10.4049/jimmunol.166.9.5331

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

Review 1.  Genetic analysis of CD28 signaling.

Authors:  Tiffani A Greene; Virginia Smith Shapiro
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

2.  Azathioprine: old drug, new actions.

Authors:  Jonathan S Maltzman; Gary A Koretzky
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

Review 3.  An enigmatic tail of CD28 signaling.

Authors:  Jonathan S Boomer; Jonathan M Green
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-09       Impact factor: 10.005

4.  In the absence of its cytosolic domain, the CD28 molecule still contributes to T cell activation.

Authors:  Stéphanie O Morin; Valentin Giroux; Cédric Favre; Yassina Bechah; Nathalie Auphan-Anezin; Romain Roncagalli; Jean-Louis Mège; Daniel Olive; Marie Malissen; Jacques A Nunès
Journal:  Cell Mol Life Sci       Date:  2015-03-01       Impact factor: 9.261

5.  Regulated costimulation in the thymus is critical for T cell development: dysregulated CD28 costimulation can bypass the pre-TCR checkpoint.

Authors:  Joy A Williams; Karen S Hathcock; David Klug; Yohsuke Harada; Baishakhi Choudhury; James P Allison; Ryo Abe; Richard J Hodes
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

6.  OX40 complexes with phosphoinositide 3-kinase and protein kinase B (PKB) to augment TCR-dependent PKB signaling.

Authors:  Takanori So; Heonsik Choi; Michael Croft
Journal:  J Immunol       Date:  2011-02-02       Impact factor: 5.422

7.  Functional analysis of acquired CD28 mutations identified in cutaneous T cell lymphoma.

Authors:  Grzegorz B Gmyrek; Jeanette Pingel; Jaehyuk Choi; Jonathan M Green
Journal:  Cell Immunol       Date:  2017-07-10       Impact factor: 4.868

8.  Chimeric antigen receptors combining 4-1BB and CD28 signaling domains augment PI3kinase/AKT/Bcl-XL activation and CD8+ T cell-mediated tumor eradication.

Authors:  Xiao-Song Zhong; Maiko Matsushita; Jason Plotkin; Isabelle Riviere; Michel Sadelain
Journal:  Mol Ther       Date:  2009-09-22       Impact factor: 11.454

Review 9.  CD28 Costimulation: From Mechanism to Therapy.

Authors:  Jonathan H Esensten; Ynes A Helou; Gaurav Chopra; Arthur Weiss; Jeffrey A Bluestone
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

10.  Characterizing a soluble survival signal for activated lymphocytes from CD14+ cells.

Authors:  Xiaolei Tang; David E Yocum; David DeJonghe; Kathy Nordensson
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.